Literature DB >> 23835937

Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study.

S Marlene Grenon1, Eric Vittinghoff, Christopher D Owens, Michael S Conte, Mary Whooley, Beth E Cohen.   

Abstract

Among patients with coronary artery disease (CAD), those with peripheral artery disease (PAD) have a greater vulnerability to cardiovascular (CV) events than those with CAD alone. In a prospective cohort study of patients with CAD, we evaluated potential mechanisms that might explain the adverse CV outcomes associated with PAD. We performed a prospective cohort study of 1018 patients with stable CAD who were recruited from 2000 to 2002. Incident symptomatic PAD events were adjudicated during a follow-up period of 7.2 ± 2.6 years. We used Cox proportional hazards models to evaluate the association between incident symptomatic PAD events and subsequent risk of CV events or death. Models were adjusted for demographics, traditional risk factors, inflammation, insulin resistance and health behaviors. Among the 1018 patients, 50 patients who did not report a history of PAD at baseline suffered incident symptomatic PAD events during the follow-up period. Those patients had a higher risk of subsequent CV events and death compared to those who did not develop PAD. After adjustment for traditional risk factors, symptomatic PAD events remained associated with a 70% increased risk of subsequent CV events (adjusted HR 1.7; 95% CI 1.0, 2.9; p = 0.04) and an 80% increased risk of death (adjusted HR 1.8; 95% CI 1.2, 2.7; p = 0.006). Inflammatory biomarkers were the strongest risk factor contributing to the excess risk. In a contemporary cohort of patients with CAD, incident symptomatic PAD events were associated with an increased risk for subsequent CV events. The increased vulnerability to CV events was partially explained by shared CV risk factors and inflammation.

Entities:  

Keywords:  coronary disease; peripheral artery disease

Mesh:

Substances:

Year:  2013        PMID: 23835937      PMCID: PMC4207208          DOI: 10.1177/1358863X13493825

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  40 in total

1.  Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute.

Authors:  Russell V Luepker; Fred S Apple; Robert H Christenson; Richard S Crow; Stephen P Fortmann; David Goff; Robert J Goldberg; Mary M Hand; Allan S Jaffe; Desmond G Julian; Daniel Levy; Teri Manolio; Shanthi Mendis; George Mensah; Andrzej Pajak; Ronald J Prineas; K Srinath Reddy; Veronique L Roger; Wayne D Rosamond; Eyal Shahar; A Richey Sharrett; Paul Sorlie; Hugh Tunstall-Pedoe
Journal:  Circulation       Date:  2003-11-10       Impact factor: 29.690

2.  Fate in intermittent claudication: outcome and risk factors.

Authors:  R Jelnes; O Gaardsting; K Hougaard Jensen; N Baekgaard; K H Tønnesen; T Schroeder
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-01

3.  Peripheral arterial disease and progression of coronary atherosclerosis.

Authors:  Ayman A Hussein; Kiyoko Uno; Kathy Wolski; Samir Kapadia; Paul Schoenhagen; E Murat Tuzcu; Steven E Nissen; Stephen J Nicholls
Journal:  J Am Coll Cardiol       Date:  2011-03-08       Impact factor: 24.094

4.  Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.

Authors:  P M Ridker; M J Stampfer; N Rifai
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

5.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

6.  Construct validity of self-reported historical physical activity.

Authors:  Heather R Bowles; Shannon J FitzGerald; James R Morrow; Allen W Jackson; Steven N Blair
Journal:  Am J Epidemiol       Date:  2004-08-01       Impact factor: 4.897

Review 7.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Authors:  Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone
Journal:  Circulation       Date:  2004-07-13       Impact factor: 29.690

8.  Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study.

Authors:  Helaine E Resnick; Robert S Lindsay; Mary McGrae McDermott; Richard B Devereux; Kristina L Jones; Richard R Fabsitz; Barbara V Howard
Journal:  Circulation       Date:  2004-02-17       Impact factor: 29.690

9.  Lower extremity peripheral arterial disease in hospitalized patients with coronary artery disease.

Authors:  Robert S Dieter; Jon Tomasson; Thorbjorn Gudjonsson; Roger L Brown; Mark Vitcenda; Jean Einerson; Patrick E McBride
Journal:  Vasc Med       Date:  2003-11       Impact factor: 3.239

10.  Association between endothelial dysfunction and major cardiovascular events in peripheral arterial disease.

Authors:  L Pasqualini; S Marchesi; G Vaudo; D Siepi; F Angeli; L Paris; G Schillaci; E Mannarino
Journal:  Vasa       Date:  2003-08       Impact factor: 1.961

View more
  36 in total

1.  Peripheral Artery Disease Is Associated with a Deficiency of Erythrocyte Membrane n-3 Polyunsaturated Fatty Acids.

Authors:  Joel L Ramirez; Greg J Zahner; Kimberly A Spaulding; Sukaynah A Khetani; Nancy K Hills; Warren J Gasper; William S Harris; Beth E Cohen; S Marlene Grenon
Journal:  Lipids       Date:  2019-03-18       Impact factor: 1.880

2.  Association between arterial stiffness and peripheral artery disease as measured by radial artery tonometry.

Authors:  Greg J Zahner; Magdalena A Gruendl; Kimberly A Spaulding; Melinda S Schaller; Nancy K Hills; Warren J Gasper; S Marlene Grenon
Journal:  J Vasc Surg       Date:  2017-07-26       Impact factor: 4.268

3.  Association between Peripheral Artery Disease and Major Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome: Findings from the Gulf COAST Registry.

Authors:  Ibrahim Al-Zakwani; Ekram Al Siyabi; Najib Alrawahi; Arif Al-Mulla; Abdullah Alnaeemi; Abdulla Shehab; Mohammad Zubaid
Journal:  Med Princ Pract       Date:  2019-02-10       Impact factor: 1.927

4.  Symptomatic peripheral artery disease is associated with decreased long-term survival after coronary artery bypass: a contemporary retrospective analysis.

Authors:  Teruya Nakamura; Koichi Toda; Shigeru Miyagawa; Yasushi Yoshikawa; Satsuki Fukushima; Shunsuke Saito; Daisuke Yoshioka; Shin Yajima; Shohei Yoshida; Yoshiki Sawa
Journal:  Surg Today       Date:  2016-07-21       Impact factor: 2.549

5.  Role of lipoprotein (a) in peripheral arterial disease.

Authors:  Constantine E Kosmas; Delia Silverio; Andreas Sourlas; Richard Peralta; Peter D Montan; Eliscer Guzman; Mario J Garcia
Journal:  Ann Transl Med       Date:  2019-09

6.  Radial Artery Tonometry is Associated With Major Adverse Cardiac Events in Patients With Peripheral Artery Disease.

Authors:  Joel L Ramirez; Kimberly A Spaulding; Greg J Zahner; Sukaynah A Khetani; Melinda S Schaller; Warren J Gasper; Nancy K Hills; S Marlene Grenon
Journal:  J Surg Res       Date:  2018-11-01       Impact factor: 2.192

7.  Relationship between kidney disease and endothelial function in peripheral artery disease.

Authors:  Karen C Chong; Christopher D Owens; Meyeon Park; Hugh F Alley; W John Boscardin; Michael S Conte; Warren J Gasper; S Marlene Grenon
Journal:  J Vasc Surg       Date:  2014-10-16       Impact factor: 4.268

Review 8.  Advancing beyond the "heart-healthy diet" for peripheral arterial disease.

Authors:  Emily V Nosova; Michael S Conte; S Marlene Grenon
Journal:  J Vasc Surg       Date:  2015-01       Impact factor: 4.268

9.  Guideline-directed statin intensification in patients with new or worsening symptoms of peripheral artery disease.

Authors:  Yevgeniy Khariton; Krishna K Patel; Paul S Chan; Yashashwi Pokharel; Jingyan Wang; John A Spertus; David M Safley; William R Hiatt; Kim G Smolderen
Journal:  Clin Cardiol       Date:  2018-10-19       Impact factor: 2.882

10.  Walking disability in patients with peripheral artery disease is associated with arterial endothelial function.

Authors:  S Marlene Grenon; Karen Chong; Hugh Alley; Emily Nosova; Warren Gasper; Jade Hiramoto; W John Boscardin; Christopher D Owens
Journal:  J Vasc Surg       Date:  2014-01-11       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.